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Abstrat
Prediting interations between small moleules and proteins is a ruial ingredient of the
drug disovery proess. In partiular, aurate preditive models are inreasingly used to prese-
let potential lead ompounds from large moleule databases, or to sreen for side-eets. While
lassial in silio approahes fous on prediting interations with a given spei target, new
hemogenomis approahes adopt ross-target views. Building on reent developments in the use
of kernel methods in bio- and hemoinformatis, we present a systemati framework to sreen
the hemial spae of small moleules for interation with the biologial spae of proteins. We
show that this framework allows information sharing aross the targets, resulting in a dramati
improvement of ligand predition auray for three important lasses of drug targets: enzymes,
GPCR and ion hannels.
1 Introdution
Prediting interations between small moleules and proteins is a key element in the drug disov-
ery proess. In partiular, several lasses of proteins suh as G-protein-oupled reeptors (GPCR),
enzymes and ion hannels represent a large fration of urrent drug targets and important targets
for new drug development (Hopkins and Groom, 2002). Understanding and prediting the intera-
tions between small moleules and suh proteins ould therefore help in the disovery of new lead
ompounds.
Various approahes have already been developed and have proved very useful to address this
in silio predition issue (Manly et al., 2001). The lassial paradigm is to predit the modulators
of a given target, onsidering eah target as a dierent problem. Usual methods are lassied
into ligand-based and struture-based or doking approahes. Ligand-based approahes ompare
a andidate ligand to the known ligands of the target to make their predition, typially using
mahine learning algorithms (Butina et al., 2002; Byvatov et al., 2003; Zernov et al., 2003) whereas
struture-based approahes use the 3D-struture of the target to determine how well eah andidate
binds the target (Halperin et al., 2002).
Ligand-based approahes neessitate to know enough ligands of a given target with respet to the
omplexity of the ligand/non-ligand separation to produe aurate preditors. If few or no ligands
are known for a target, one is ompelled to use doking approahes, whih in turn neessitate to know
the 3D struture of the target and are very time onsuming. If for a given target with unavailable
3D struture no ligand is known, none of the lassial approahes an apply. This is the ase for
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many GPCR as very few strutures have been rystallized so far (Ballesteros and Palzewski, 2001)
and many of these reeptors, referred to as orphan GPCR, have no known ligand.
An interesting way to solve this problem is to ast it in the hemogenomis framework. Chemoge-
nomis aims at mining the hemial spae, whih roughly orresponds to the set of all small
moleules, for interations with the biologial spae, i.e., the set of all proteins, in partiular drug
targets. A salient feature of the hemogenomis approah is the realization that some lasses of
moleules an bind similar proteins, suggesting that the knowledge of some ligands for a target
an be helpful to determine ligands for similar targets. Besides, this type of method allows for a
more rational approah to design drugs sine ontrolling a whole ligand's seletivity prole is ruial
to make sure that no side eet ours and that the ompound is ompatible with therapeutial
usage.
Reent reviews (Kubinyi et al., 2004; Jaroh and Weinmann, 2006; Klabunde, 2007; Rognan,
2007) list several hemogenomi approahes to predit interations between ompounds and tar-
gets (Olo et al., 2006; Bok and Gough, 2005). Many of these hemogenomis methods rely on
some xed hoie of whih targets should be used when learning a preditor for a given target,
the most extreme example being the learning of a preditor for a whole family or subfamily of
targets (Balakin et al., 2002; Klabunde, 2006). Most of them also need some spei proedure to
hoose whih ligands of the seleted targets are used and how they are used.
We propose a method that uses existing and well tested mahine learning algorithms, asting the
interation predition problem in a joint ligand-target spae. This embeds the sharing level threshold
problem in a simple representation hoie for whih we also propose a systemati approah based
on ombinations of features of the ligand and features of the target. For the three families of targets
of interest, we show that our approah outperforms the state-of-the-art individual SVM, and gives
good performanes even for targets with no known ligand.
2 Method
We formulate the typial in silio hemogenomis problem as the following learning problem: given a
olletion of n target/moleule pairs (t1, c1), . . . (tn, cn) known to interat or not, estimate a funtion
f(t, c) that would predit whether any hemial c binds to any target t. In this setion we propose
a rigorous and general framework to solve this problems, building on reent developments of kernel
methods in bio- and hemoinformatis.
2.1 From single-target sreening to hemogenomis
Muh eort in hemoinformatis has been devoted to the more restrited problem of mining the
hemial spae for interation with a single target t, using a training set of moleules c1, . . . , cn known
to interat or not with the target. Mahine learning approahes, suh as artiial neural networks
(ANN) or support vetor mahines (SVM), often provide ompetitive models for suh problems.
The simplest linear models start by representing eah moleule c by a vetor representation Φ(c),
before estimating a linear funtion ft(c) = w
⊤
t Φ(c) whose sign (positive or negative) is used to
predit whether or not the small moleule c is a ligand of the target t. The weight vetor wt is
typially estimated based on its ability to orretly predit the lasses of moleules in the training
set.
The in silio hemogenomis problem is more general beause data involving interations with
dierent targets are available to train a model whih must be able to predit interations between
any moleule and any protein. In order to extend the previous mahine learning approahes to this
setting, we need to represent a pair (t, c) of target t and hemials c by a vetor Φ(t, c), then estimate
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a linear funtion f(t, c) = w⊤Φ(t, c) whose sign is used to predit whether or not c an bind to t.
As before the vetor w an be estimated from the training set of interating and non-interating
pairs, using any linear mahine learning algorithm.
To summarize, we propose to ast the in silio hemogenomis problem as a learning problem
in the ligand-target spae thus making it suitable to any lassial linear mahine learning approah
as soon as a vetor representation Φ(t, c) is hosen for protein/ligand pairs. We propose in the next
setions a systemati way to design suh a representation.
2.2 Vetor representation of target/ligand pairs
A large literature in hemoinformatis has been devoted to the problem of representing a moleule
t by a vetor Φligand(c) ∈ R
dc
, e.g., using various moleular desriptors (Todeshini and Consonni,
2002). These desriptors enode several features related to the physio-hemial and strutural
properties of the moleules, and are widely used to model interations between the small moleules
and a single target using linear models desribed in the previous setion (Gasteiger and Engel, 2003).
Similarly, muh work in omputational biology has been devoted to the onstrution of desriptors
for genes and proteins, in order to represent a given protein t by a vetor Φtarget(t) ∈ R
dt
. The
desriptors typially apture properties of the sequene or struture of the protein, and an be used
to infer models to predit, e.g., the strutural or funtional lass of a protein.
For our in silio hemogenomis problem we need to represent eah pair (c, t) of small moleule
and protein by a single vetor Φ(c, t). In order to apture interations between features of the
moleule and of the protein that may be useful preditors for the interation between c and t, we
propose to onsider features for the pair (c, t) obtained by multiplying a desriptor of c with a
desriptor of t. Intuitively, if for example the desriptors are binary indiators of spei strutural
features in eah small moleule and proteins, then the produt of two suh features indiates that
both the small moleule and the target arry spei features, whih may be strongly orrelated with
the fat that they interat. More generally, if a moleule c is represented by a vetor of desriptors
Φligand(c) ∈ R
dc
and a target protein by a vetor of desriptors Φtarget(t) ∈ R
dt
, this suggests to
represent the pair (c, t) by the set of all possible produts of features of c and t, i.e., by the tensor
produt:
Φ(c, t) = Φligand(c) ⊗Φtarget(t) . (1)
Remember that the tensor produt in (1) is a dc × dt vetor whose (i, j)-th entry is exatly the
produt of the i-th entry of Φligand(c) by the j-th entry of Φtarget(t). This representation an be
used to ombine in a prinipled way any vetor representation of small moleules with any vetor
representation of proteins, for the purpose of in silio hemogenomis or any other task involving
pairs of moleules/protein. A potential issue with this approah, however, is that the size of the
vetor representation for a pair may be prohibitively large for pratial omputation and storage.
For example, using a vetor of moleular desriptors of size 1024 for moleules and representing a
protein by the vetor of ounts of all 2-mers of amino-aids in its sequene (dt = 20 × 20 = 400)
results in more than 400k dimensions for the representation of a pair. In order to irumvent this
issue we now show how kernel methods suh as SVM an eiently work in suh large spaes.
2.3 Kernels for target/ligand pairs
SVM is an algorithm to estimate linear binary lassiers from a training set of patterns with known
lass (Boser et al., 1992; Vapnik, 1998). A salient feature of SVM, often referred to as the ker-
nel trik, is its ability to proess large- or even innite-dimensional patterns as soon as the in-
ner produt between any two patterns an be eiently omputed. This property is shared by
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a large number of popular linear algorithms, olletively referred to as kernel methods, inluding
for example algorithms for regression, lustering or outlier detetion (Shölkopf and Smola, 2002;
Shawe-Taylor and Cristianini, 2004).
In order to apply kernel methods suh as SVM for in silio hemogenomis, we therefore need
to show how to eiently ompute the inner produt between the vetor representations of two
moleule/protein pairs. Interestingly, a lassial and easy to hek property of tensor produts
allows to write the inner produt between two tensor produt vetors as a produt of inner produts:
(Φligand(c)⊗ Φtarget(t))
⊤
(
Φligand(c
′)⊗ Φtarget(t
′)
)
= Φligand(c)
⊤Φligand(c
′)×Φtarget(t)
⊤Φtarget(t
′) .
(2)
This fatorization dramatially redues the burden of working with tensor produts in large di-
mensions. For example, in our previous example where the dimensions of the small moleule and
proteins are vetors of respetive dimensions 1024 and 400, the inner produt in > 400k dimensions
between tensor produts is simply obtained from (2) by omputing two inner produts, respetively
in dimensions 1024 and 400, before taking their produt.
Even more interestingly, this reasoning extends to the ase where inner produts between vetor
representations of small moleules and proteins an themselves be eiently omputed with the
help of positive denite kernels (Vapnik, 1998), as explained in the next setions. Positive denite
kernels are linked to inner produts by a fundamental result (Aronszajn, 1950): the kernel between
two points is equivalent to an inner produt between the points mapped to a Hilbert spae uniquely
dened by the kernel. Now by denoting
Kligand(c, c
′) = Φligand(c)
⊤Φligand(c
′) , Ktarget(t, t
′) = Φtarget(t)
⊤Φtarget(t
′) ,
we obtain the inner produt between tensor produts by:
K
(
(c, t), (c′, t′)
)
= Ktarget(t, t
′)×Kligand(c, c
′). (3)
In summary, as soon as two kernelsKligand andKtarget orresponding to two impliit embeddings
of the hemial and biologial spaes in two Hilbert spaes are hosen, we an solve the in silio
hemogenomis problem with an SVM (or any other relevant kernel method) using the produt
kernel (3) between pairs. The partiular kernels Kligand and Ktarget should ideally enode properties
related to the ability of similar moleules to bind similar targets or ligands respetively. We review
in the next two setions possible hoies for suh kernels.
2.4 Kernels for ligands
Reent years have witnessed impressive advanes in the use of SVM in hemoinformatis (Ivaniu,
2007). In partiular muh work has foused on the development of kernels for small moleules
for the purpose of single-target virtual sreening and predition of pharmaokinetis and toxi-
ity. For example simple inner produts between vetors of lassial moleular desriptors have
been widely investigated, inluding physiohemial properties of moleules or 2D and 3D nger-
prints (Todeshini and Consonni, 2002; Azenott et al., 2007). Other kernels have been designed
diretly from the omparison of 2D and 3D strutures of moleules, inluding kernels based on the
detetion of ommon substrutures in the 2D strutures moleules seen as graphs (Kashima et al.,
2003, 2004; Gärtner et al., 2003; Mahé et al., 2005; Ralaivola et al., 2005; Borgwardt and Kriegel,
2005; Ramon and Gärtner, 2003; Horváth et al., 2004; Mahé and Vert, 2006) or on the enoding of
various properties of the 3D struture of a moleules (Mahé et al., 2006; Azenott et al., 2007).
While any of these kernels ould be used to model the similarities of small moleules and be
plugged into (3), we restrit ourselves in our experiment to a partiular kernel proposed by Ralaivola et al.
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(2005) alled the Tanimoto kernel, a lassial hoie that usually gives state-of-the-art performanes
in moleule lassiation tasks. It is dened as:
Kligand(c, c
′) =
Φligand(c)
⊤Φligand(c
′)
Φligand(c)⊤Φligand(c) + Φligand(c′)⊤Φligand(c′)−Φligand(c)⊤Φligand(c′)
, (4)
where Φligand(c) is a binary vetor whose bits indiate the presene or absene of all linear path
of length l or less as subgraph of the 2D struture of c. We hose l = 8 in our experiment,
i.e., haraterize the moleules by the ourrenes of linear subgraphs of length 8 or less, a value
previously observed to give good results in several virtual sreening task Mahé et al. (2005). We used
the freely and publily available ChemCPP
1
software to ompute this kernel in the experiments.
2.5 Kernels for targets
SVM and kernel methods are also widely used in bioinformatis (Shölkopf et al., 2004), and
a variety of approahes have been proposed to design kernels between proteins, ranging from
kernels based on the amino-aid sequene of a protein (Jaakkola et al., 2000; Leslie et al., 2002;
Tsuda et al., 2002; Ben-Hur and Brutlag, 2003; Leslie et al., 2004; Vert et al., 2004; Kuang et al.,
2005; Cuturi and Vert, 2005) to kernels based on the 3D strutures of proteins (Dobson and Doig,
2005; Borgwardt et al., 2005; Qiu et al., 2007) or the pattern of ourrenes of proteins in multiple
sequened genomes (Vert, 2002). These kernels have been used in onjuntion with SVM or other
kernel methods for various tasks related to strutural or funtional lassiation of proteins. While
any of these kernels an theoretially be used as a target kernel in (3), we investigate in this pa-
per a restrited list of spei kernels desribed below, aimed at illustrating the exibility of our
framework and test various hypothesis.
• The Dira kernel between two targets t, t′ is:
KDirac(t, t
′) =
{
1 if t = t′ ,
0 otherwise.
(5)
This basi kernel simply represents dierent targets as orthonormal vetors. From (3) we
see that orthogonality between two proteins t and t′ implies orthogonality between all pairs
(c, t) and (c′, t′) for any two small moleules c and c′. This means that a linear lassier for
pairs (c, t) with this kernel deomposes as a set of independent linear lassiers for interations
between moleules and eah target protein, whih are trained without sharing any information
of known ligands between dierent targets. In other words, using Dira kernel for proteins
amounts to performing lassial learning independently for eah target, whih is our baseline
approah.
• The multitask kernel between two targets t, t′ is dened as:
Kmultitask(t, t
′) = 1 +KDirac(t, t
′) .
This kernel, originally proposed in the ontext of multitask learning Evgeniou et al. (2005),
removes the orthogonality of dierent proteins to allow sharing of information. As explained in
Evgeniou et al. (2005), plugging Kmultitask in (3) amounts to deomposing the linear funtion
1
Available at http://hempp.soureforge.net.
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used to predit interations as a sum of a linear funtion ommon to all targets and of a linear
funtion spei to eah target:
f(c, t) = w⊤Φ(c, t) = w⊤generalΦligand(c) + w
⊤
t Φligand(c) .
A onsequene is that only data related to the the target t are used to estimate the spei
vetor wt, while all data are used to estimate the ommon vetor wgeneral. In our framework
this lassier is therefore the ombination of a target-spei part aounting for target-spei
properties of the ligands and a global part aounting for general properties of the ligands
aross the targets. The latter term allows to share information during the learning proess,
while the former ensures that speiities of the ligands for eah target are not lost.
• While the multitask kernel provides a basi framework to share information aross proteins, it
does not allow to weight dierently how known interations with a protein t should ontribute
to predit interations with a target t′. Empirial observations underlying hemogenomis,
on the other hand, suggest that moleules binding a ligand t are only likely to bind ligand t′
similar to t in terms of struture or evolutionary history. In terms of kernels this suggest to
plug into (3) a kernel for proteins that quanties this notion of similarity between proteins,
whih an for example be deteted by omparing the sequenes of proteins. In order to test
this approah, we therefore tested two ommonly-used kernels between protein sequenes:
the mismath kernel (Leslie et al., 2004), whih ompares proteins in terms of ommon short
sequenes of amino aids up to some mismathes, and the loal alignment kernel (Vert et al.,
2004) whih measures the similarity between proteins as an alignment sore between their
primary sequenes. In our experiments involving the mismath kernel, we use the lassial
hoie of 3-mers with a maximum of 1 mismath, and for the datasets where some sequenes
were not available in the database, we added KDirac(t, t
′) to the kernel (and normalized at 1
on the diagonal) in order to keep it valid.
• Alternatively we propose a new kernel aimed at enoding the similarity of proteins with
respet to the ligands they bind. Indeed, for most major lasses of drug targets suh as
the ones investigated in this study (GPCR, enzymes and ion hannels), proteins have been
organized into hierarhies that typially desribe the preise funtions of the proteins within
eah family. Enzymes are labeled with Enzyme Commission numbers (EC numbers) dened
in International (1992), that lassify the hemial reation they atalyze, forming a 4-level
hierarhy enoded into 4 numbers. For example EC 1 inludes oxydoredutases, EC 1.2
inludes oxidoredutases that at on the aldehyde or oxo group of donors, EC 1.2.2 is a
sublass of EC 1.2 with NAD+ or NADP+ as aeptor and EC 1.2.2.1 is a subgroup of
enzymes atalyzing the oxidation of formate to biarbonate. These number dene a natural
and very informative hierarhy on enzymes: one an expet that enzymes that are loser in
the hierarhy will tend to have more similar ligands. Similarly, GPCRs are grouped into 4
lasses based on sequene homology and funtional similarity: the rhodopsin family (lass A),
the seretin family (lass B), the metabotropi family (lass C) and a last lass regrouping
more diverse reeptors (lass D). The KEGG database (Kanehisa et al., 2002) subdivides
the large rhodopsin family in three subgroups (amine reeptors, peptide reeptors and other
reeptors) and adds a seond level of lassiation based on the type of ligands or known
subdivisions. For example, the rhodopsin family with amine reeptors is subdivided into
holinergi reeptors, adrenergi reeptors, et. This also denes a natural hierarhy that we
ould use to ompare GPCRs. Finally, KEGG also provides a lassiation of ion hannels.
Classiation of ion hannels is a less simple task sine some of them an be lassied aording
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to dierent riterions like voltage dependene or ligand-gating. The lassiation proposed by
KEGG inludes Cys-loop superfamily, glutamate-gated ation hannels, epithelial and related
Na+ hannels, voltage-gated ation hannels, related to voltage-gated ation hannels, related
to inward retier K+ hannels, hloride hannels and related to ATPase-linked transporters
and eah of these lasses is further subdivided aording for example to the type of ligands (e.g.,
glutamate reeptor) or to the type of ion passing through the hannel (e.g., Na+ hannel).
Here again, this hierarhy an be used to dene a meaningful similarity in terms of interation
behavior.
For eah of the three target families, we dene the hierarhy kernel between two targets of the
family as the number of ommon anestors in the orresponding hierarhy plus one, that is,
Khierarchy(t, t
′) = 〈Φh(t),Φh(t
′)〉,
where Φh(t) ontains as many features as there are nodes in the hierarhy, eah being set to 1
if the orresponding node is part of t's hierarhy and 0 otherwise, plus one feature onstantly
set to one that aounts for the "plus one" term of the kernel.
3 Data
We extrated ompound interation data from the KEGG BRITE Database (Kanehisa et al., 2002,
2004) onerning enzyme, GPCR and ion hannel, three target lasses partiularly relevant for novel
drug development.
For eah family, the database provides a list of known ompounds for eah target. Depending on
the target families, various ategories of ompounds are dened to indiate the type of interation
between eah target and eah ompound. These are for example inhibitor, ofator and eetor for
enzyme ligands, antagonist or (full/partial) agonist for GPCR and pore bloker, (positive/negative)
allosteri modulator, agonist or antagonist for ion hannels. The list is not exhaustive for the latter
sine numerous ategories exist. Although dierent types of interations on a given target might
orrespond to dierent binding sites, it is theoretially possible for a non-linear lassier like SVM
with non-linear kernels to learn lasses onsisting of several disonneted sets. Therefore, for the
sake of larity of our analysis, we do not dierentiate between the ategories of ompounds.
We eliminated all ompounds for whih no moleular desriptor was available (prinipally peptide
ompounds), and all the targets for whih no ompound was known. For eah target, we generated
as many negative ligand-target pairs as we had known ligands forming positive pairs by ombining
the target with a ligand randomly hosen among the other target's ligands (exluding those that
were known to interat with the given target). This protool generates false negative data sine
some ligands ould atually interat with the target although they have not been experimentally
tested, and our method ould benet from experimentally onrmed negative ouples.
This resulted in 2436 data points for enzymes (1218 known enzyme-ligand pairs and 1218 gen-
erated negative points) representing interations between 675 enzymes and 524 ompounds, 798
training data points for GPCRs representing interations between 100 reeptors and 219 om-
pounds and 2330 ion hannel data points representing interations between 114 hannels and 462
ompounds. Besides, Figure 1 shows the distribution of the number of known ligands per target for
eah dataset and illustrates the fat that for most of them, few ompounds are known.
For eah target t in eah family, we arried out two experiments. First, all data points orre-
sponding to other targets in the family were used for training only and the nt points orresponding
to t were k-folded with k = min(nt, 10). That is, for eah fold, an SVM lassier was trained on
all points involving other targets of the family plus a fration of the points involving t, then the
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Figure 1: Distribution of the number of training points for a target for the enzymes, GPCR and
ion hannel datasets.
performanes of the lassier were tested on the remaining fration of data points for t. This pro-
tool is intended to assess the inidene of using ligands from other targets on the auray of the
learned lassier for a given target. Seond, for eah target t we learned an SVM lassier using
only interations that did not involve t and tested on the points that involved t. This is intended to
simulate the behavior of our framework when making preditions for orphan targets, i.e., for targets
for whih no ligand is known.
For the rst protool, sine learning an SVM with only one training point does not really make
sense and an lead to "anti-learning" less than 0.5 performanes, we set all results r involving
the Dira target kernel on targets with only 1 known ligand to max(r, 0.5). This is to avoid any
artefatual penalization of the Dira approah and make sure we measure the atual improvement
brought by sharing information aross targets.
4 Results
We rst expose the results obtained on the three datasets for the rst experiment, assessing how
using training points from other targets of the family improves predition auray with respet to
individual (Dira-based) learning. Table 1 shows the mean suess rate aross the family targets
for an SVM with a produt kernel using the Tanimoto kernel for ligands and various kernels for
proteins. For the enzymes and ion hannels datasets, we observe signiant improvements when the
Figure 2: Target kernel Gram matries (Ktar) for ion hannels with multitask, hierarhy and loal
alignment kernels.
multitask kernel is used in plae of the Dira kernel, on the one hand, and when the hierarhy kernel
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replaes the multitask kernel, on the other hand. For example, the Dira kernel only performs at
an average auray of 70% for the ion hannel dataset, while the multitask kernel inreases the
auray to 80% and the hierarhy kernel brings it to 88%. For the enzymes, a global improvement
of 34.1% is observed between the Dira and the hierarhy approahes. This learly demonstrates
the benets of sharing information among known ligands of dierent targets, on the one hand, and
the relevane of inorporating prior information into the kernels, on the other hand.
On the GPCR dataset though, the multitask kernel performs worse than the Dira kernel,
probably beause some targets in dierent sublasses show very dierent binding behavior whih
results in adding more noise than information when sharing naively with this kernel. However a
more areful handling of the similarities between GPCRs through the hierarhy kernel again results
in signiant improvement over the Dira kernel (from 68.2% to 81.7%), again demonstrating the
relevane of the approah.
Sequene-based target kernels do not ahieve the same performane as the hierarhy kernel,
although they perform relatively well for the ion hannel dataset. In the ase of enzymes, it an
be explained by the diversity of the proteins in the family and for the GPCR, by the well known
fat that the reeptors do not share overall sequene homology (Gether, 2000). Figure 2 shows 3
of the tested target kernels for the ion hannel dataset. The hierarhy kernel adds some struture
information with respet to the multitask kernel, whih explains the suess rate inrease. The
loal alignment sequene-based kernels fail to preisely re-build this struture but retains some
substrutures. In the ases of GPCR and enzymes, almost no struture is found by the sequene
kernels, whih, as alluded to above, was expetable and suggests that more subtle omparison of
the sequenes would be required to exploit the information they ontain.
Figure 3 illustrates the inuene of the number of training points for a target on the improvement
brought by using information from similar targets. As one ould expet, the improvement is very
strong when few ligands are known and dereases when enough training points beome available.
After a ertain point (around 30 training points), using similar targets an even deteriorates the
performanes. This suggests that the method ould be globally improved by learning for eah
target independently how muh information should be shared, for example through kernel learning
approahes (Lankriet et al., 2004).
Ktar\ Target Enzymes GPCR Channels
Dira 0.536 ± 0.005 0.682 ± 0.022 0.701 ± 0.017
multitask 0.874 ± 0.008 0.595 ± 0.030 0.797 ± 0.017
hierarhy 0.877 ± 0.008 0.817 ± 0.025 0.857 ± 0.015
mismath 0.582 ± 0.008 0.638 ± 0.030 0.811 ± 0.016
loal alignment 0.544 ± 0.007 0.696 ± 0.033 0.824 ± 0.015
Table 1: Predition auray for the rst protool on eah dataset with various target kernels.
The seond experiment aims at pushing this remark to its limit by assessing how eah strategy
is able to predit ligands for proteins with no known ligand. Table 2 shows the results in that
ase. As expeted, the lassiers using Dira kernels show random behavior in this ase sine using
a Dira kernel with no data for the target amounts to learning with no training data at all. On
the other hand we note that it is still possible to obtain reasonable results using adequate target
kernels. In partiular, the hierarhy kernel loses only 5.2% for the ion hannel dataset, 4.1% for
the GPCR dataset and 1.5% ompared to the rst experiment where known ligands were used,
suggesting that if a target with no known ompound is plaed in the hierarhy through, e.g. in
the ase of GPCR homology detetion with known members of the family using spei GPCR
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Figure 3: Relative improvement of the hierarhy kernel against the Dira kernel as a funtion of
the number of known ligands for enzymes, GPCR and ion hannel datasets.
alignment algorithms (Kratohwil et al., 2005) or ngerprint analysis (Attwood et al., 2003), it is
possible to predit some of its ligands almost as aurately as if some of them were already available.
Ktar\ Target Enzymes GPCR Channels
Dira 0.500 ± 0.000 0.500 ± 0.000 0.500 ± 0.000
multitask 0.856 ± 0.009 0.477 ± 0.025 0.636 ± 0.021
hierarhy 0.862 ± 0.009 0.776 ± 0.026 0.805 ± 0.018
mismath 0.569 ± 0.007 0.579 ± 0.028 0.671 ± 0.020
loal alignment 0.521 ± 0.004 0.647 ± 0.030 0.722 ± 0.019
Table 2: Predition auray for the seond protool on eah dataset with various target kernels.
5 Disussion
We propose a general method to ombine the hemial and the biologial spae in a prinipled
way and predit interation between any small moleule and any target, whih makes it a vary
valuable tool for drug disovery. The method allows to represent systematially a ligand-target
ouple, inluding information on the interation between the ligand and the target. Predition is
then performed by any mahine learning algorithm (an SVM in our ase) in the joint spae, whih
makes targets with few known ligands benet from the data points of similar targets, and whih
allows to make preditions for targets with no known ligand. Our information sharing proess
therefore simply relies on a desription hoie for the ligands, another one for the targets and on
lassial mahine learning methods: everything is done by asting the problem in a joint spae
and no expliit proedure to selet whih part of the information is shared is needed. Sine it
subdivides the representation problem into two subproblems, our approah makes use of previous
work on kernels for moleular graphs and kernels for biologial targets. For the same reason, it
will automatially benet from future improvements in both elds. This leaves plenty of room to
inrease the performane.
Results on experimental ligand datasets show that using target kernels allowing to share infor-
mation aross the targets onsiderably improve the predition, espeially in the ase of targets with
few known ligands. The improvement is partiularly strong when the target kernel uses prior infor-
mation on the struture between the targets, e.g., a hierarhy dened on a target lass. Although
sequene kernels did not give very good results in our experiments, we believe using the target
10
sequene information ould be an interesting alternative or omplement to the hierarhy kernel.
Further improvement ould ome from the use of kernel for strutures in the ases where 3D stru-
ture information is available (e.g. for the enzymes, but not for the GPCR). Our method also shows
good performanes even when no ligand at all is known for a given target, whih is exellent news
sine lassial ligand based approahes fail to predit ligand for these targets in the one hand, and
doking approahes are omputationally expensive and not feasible when the target 3D struture is
unknown whih is the ase of GPCR in the other hand.
In future work, it ould be interesting to apply this framework to quantitative predition of
binding anity using regression methods in the joint spae. It would also be important to onrm
predited ligands experimentally or at least by doking approahes when the target 3D struture is
available.
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